γ-TuRC heterogeneity revealed by analysis of Mozart1 by Tovey, C, Tubman, C, Hamrud, E, Zhu, Z, Dyas, A, Butterfield, A, Fyfe, A, Johnson, E, Conduit, P

The role of activins in hepcidin regulation during malaria by Spottiswoode, N, Armitage, A, Williams, A, Fyfe, A, Biswas, S, Hodgson, S, Llewyllyn, D, Choudhary, P, Draper, S, Duffy, P, Drakesmith, A

Functional characterization and comparison of Plasmodium falciparum proteins as targets of transmission-blocking antibodies by Nikolaeva, D, Illingworth, J, Miura, K, Alanine, D, Brian, I, Li, Y, Fyfe, A, Da, D, Cohuet, A, Long, C, Draper, S, Biswas, S

Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology. by Li, Y, Leneghan, D, Miura, K, Nikolaeva, D, Brian, I, Dicks, M, Fyfe, A, Zakutansky, S, de Cassan, S, Long, C, Draper, S, Hill, A, Hill, F, Biswas, S

Convalescent plasma therapy for the treatment of patients with COVID‐19: Assessment of methods available for antibody detection and their correlation with neutralising antibody lev... by Harvala, H, Robb, ML, Watkins, N, Ijaz, S, Dicks, S, Patel, M, Supasa, P, Wanwisa, D, Liu, C, Mongkolsapaya, J, Bown, A, Bailey, D, Vipond, R, Grayson, N, Temperton, N, Gupta, S, Ploeg, RJ, Bolton, J, Fyfe, A, Gopal, R, Simmonds, P, Screaton, G, Thompson, C, Brooks, T, Zambon, M, Miflin, G, Roberts, DJ

SARS-CoV-2 antibody prevalence, titres and neutralising activity in an antenatal cohort, United Kingdom, 14 April to 15 June 2020 by Lumley, SF, Eyre, DW, McNaughton, AL, Howarth, A, Hoosdally, S, Hatch, SB, Kavanagh, J, Chau, KK, Downs, LO, Cox, S, Dunn, L, Justice, A, Wareing, S, Dingle, K, Rudkin, J, Auckland, K, Fyfe, A, Bolton, J, Paton, R, Mentzer, AJ, Jeffery, K, Andersson, MI, James, T, Peto, TEA, Marsden, BD, Screaton, G, Cornall, RJ, Klenerman, P, Ebner, D, Stuart, DI, Crook, DW, Stoesser, N, Kennedy, SH, Thompson, C, Gupta, S, Matthews, PC

Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020 by Thompson, CP, Grayson, N, Paton, R, Bolton, JS, Lourenco, J, Penman, B, Lee, LN, Odon, V, Mongkolsapaya, J, Chinnakannan, S, Dejnirattisai, W, Edmans, M, Fyfe, A, Imlach, C, Kooblall, K, Lim, N, Liu, C, Lopez-Camacho, C, McInally, C-A, McNaughton, AL, Ramamurthy, N, Ratcliff, J, Supasa, P, Wang, B, Mentzer, AJ, Turner, M, Sampson, O, Semple, C, Baillie, JK, ISARIC4C Investigators, Harvala, H, Screaton, G, Temperton, N, Klenerman, P, Jarvis, L, Gupta, S, Simmonds, P

The antigenic anatomy of SARS-CoV-2 receptor binding domain by Dejnirattisai, W, Zhou, D, Ginn, HM, Duyvesteyn, HME, Spasa, D, Case, JB, Zhao, Y, Walter, TS, Mentzer, AJ, Liu, C, Wang, B, Paesen, GC, Slon-Campus, J, López-Camacho, C, Kafai, NM, Bailey, AL, Chen, RE, Ying, B, Thompson, C, Bolton, J, Fyfe, A, Gupta, S, Tan, TK, Gilbert-Jaramillo, J, James, W, Knight, M, Carroll, MW, Skelly, D, Dold, C, Peng, Y, Levin, R, Dong, T, Pollard, AJ, Knight, JC, Klenerman, P, Temperton, N, Hall, DR, Williams, MA, Paterson, NG, Bertram, FKR, Seibert, CA, Clare, DK, Howe, A, Raedecke, J, Song, Y, Townsend, AR, Huang, K-YA, Fry, EE, Mongkolsapaya, J, Diamond, MS, Ren, J, Stuart, DI, Screaton, GR

Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses by McNaughton, AL, Paton, RS, Edmans, M, Youngs, J, Wellens, J, Phalora, P, Fyfe, A, Belij-Rammerstorfer, S, Bolton, JS, Ball, J, Carnell, GW, Dejnirattisai, W, Dold, C, Eyre, DW, Hopkins, P, Howarth, A, Kooblall, K, Klim, H, Leaver, S, Lee, LN, López-Camacho, C, Lumley, SF, Macallan, DC, Mentzer, AJ, Provine, NM, Ratcliff, J, Slon-Compos, J, Skelly, D, Stolle, L, Supasa, P, Temperton, N, Walker, C, Wang, B, Wyncoll, D, Simmonds, P, Lambe, T, Baillie, JK, Semple, MG, Openshaw, PJM, Obolski, U, Turner, M, Carroll, M, Mongkolsapaya, J, Screaton, G, Kennedy, SH, Jarvis, L, Barnes, E, Dunachie, S, Lourenço, J, Matthews, PC, Bicanic, T, Klenerman, P, Gupta, S, Thompson, CP